Viewing Study NCT00055263



Ignite Creation Date: 2024-05-05 @ 11:29 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00055263
Status: COMPLETED
Last Update Posted: 2009-07-28
First Post: 2003-02-21

Brief Title: A New Formulation of Calcitriol DN-101 in Patients With Advanced Malignancies
Sponsor: Novacea
Organization: Novacea

Study Overview

Official Title: A Phase I Open Label Dose Escalation Study of a New Formulation of Calcitriol DN-101 for Safety Tolerability and Pharmacokinetics in Patients With Advanced Malignancies
Status: COMPLETED
Status Verified Date: 2003-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purposes of this study are to

Test the safety of DN-101 in patients with advanced malignancies
Understand how fast the body absorbs processes and eliminates DN-101
Determine the highest dose of DN-101 that is well tolerated by cancer patients
Learn how fast the body absorbs processes and eliminates DN-101 compared to the approved product
Detailed Description: Calcitriol at low doses is approved by the FDA for use in patients with chronic renal failure However much higher doses of calcitriol are needed for any possible anti-cancer effect DN-101 is a new capsule that contains 30 times the amount of calcitriol found in the currently available calcitriol capsule In order to take an amount of calcitriol equivalent to 1 capsule of DN-101 cancer patients would need to swallow 30 pills of the approved low dose formulation

DN-101 is a pill containing calcitriol a chemical related to vitamin D that is immediately active in your body The natural vitamin D found in dairy products or in typical vitamin pills must be chemically changed by your liver and kidney into calcitriol before it is active High doses of calcitriol had anti-cancer effects when tested in animals DN-101 may have anticancer effects in your kind of cancer

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None